NYSE · Medical Care Facilities · USD
Encompass Health Corporation (EHC) Stock Analysis
Encompass Health Corporation (EHC) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
EHC Key Statistics
As of Sep 4, 2026Trading
- Open
- $121.53
- Previous Close
- $122.59
- Day's Range
- 121.53–122.62
- 52-Week Range
- 92.77–127.99
- Volume
- 517.70K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.61
Valuation
- Market Cap
- $12.01B
- P/E Ratio
- 20.43
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 18.24
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.41
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.94
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 5.96
Financials (FY)
- Revenue (FY)
- $5.94B+10.46%
- Net Income (FY)
- $566.20M+24.25%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 10.01%
- Shares Outstanding
- 98.65M
- 1-Year Return
- −1.46%
Dividend and dates
- Dividend
- $0.84+0.69%
- Ex-Dividend Date
- October 1, 2026
- Earnings Date
- October 28, 2026estimated
- Avg Volume
- 1.01M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
EHC Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +15.39% |
| 2025 | +15.67% |
| 2024 | +39.17% |
| 2023 | +12.62% |
| 2022 | +17.01% |
| 2021 | −19.90% |
| 2020 | +21.42% |
| 2019 | +14.26% |
| 2018 | +26.89% |
| 2017 | +22.36% |
| 2016 (partial year) | −0.87% |
As of September 4, 2026.
EHC Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $5.94B | $566.20M | 9.5% |
| 2024 | $5.37B | $455.70M | 8.5% |
| 2023 | $4.80B | $352.00M | 7.3% |
| 2022 | $4.35B | $271.00M | 6.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $5.94B | $5.68B | $1.05B | $566.20M | 9.5% |
| 2024 | $5.37B | $2.23B | $864.50M | $455.70M | 8.5% |
| 2023 | $4.80B | $1.98B | $731.80M | $352.00M | 7.3% |
| 2022 | $4.35B | $1.75B | $630.20M | $271.00M | 6.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
EHC Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $0.57 | 3 | — |
| 2025 | $0.70 | 4 | +48.9% |
| 2024 | $0.47 | 3 | −21.7% |
| 2023 | $0.60 | 4 | −25.3% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $0.57 | 3 | — |
| 2025 | $0.70 | 4 | +48.9% |
| 2024 | $0.47 | 3 | −21.7% |
| 2023 | $0.60 | 4 | −25.3% |
| 2022 | $0.80 | 4 | −9.9% |
| 2021 | $0.89 | 4 | +0.0% |
| 2020 | $0.89 | 4 | +1.8% |
| 2019 | $0.88 | 4 | +5.8% |
| 2018 | $0.83 | 4 | +6.1% |
| 2017 | $0.78 | 4 | +104.2% |
| 2016 | $0.38 | 2 | — |
Most recent payment: $0.19 per share, ex-dividend July 1, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
EHC Valuation vs Medical Care Facilities Median
Median of 57 stocks| Metric | EHC | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 20.43 | 19.84 | 3% above |
| P/S ratio | 1.94 | 0.95 | 104% above |
| Profit margin | 10.01% | 3.06% | 7.0 pts above |
Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
YahooEncompass Health Is Healthy Enough To Justify A Bullish View
SeekingAlphaHow EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
YahooEncompass Health (EHC) Could Be 19% Undervalued On Its Growth Narrative
YahooEncompass Health (EHC) Stock Gets Fair Value Bump After Analysts Lift Targets
YahooEncompass Health (EHC) Stock May Be 16% Undervalued As Cash Flow Holds Up
Yahoo
All 20 articles ↓Show fewer ↑
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio
YahooEncompass Health Files For Mixed Shelf Offering, Size Not Disclosed
BenzingaWhat Three Encompass Health Insiders Selling Signals After a Rate Increase
YahooEncompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know
YahooShould You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know
Yahoo5 Revealing Analyst Questions From Encompass Health’s Q2 Earnings Call
YahooEncompass Health (EHC) Q2 2026 Earnings Call Transcript
YahooEncompass Health prices private offering of additional 5.875% senior notes due 2034
YahooEHC Q2 Deep Dive: Higher-Acuity Growth, Expansion Plans, and Labor Initiatives Shape Outlook
YahooEncompass Health announces launch of private offering of 5.875% senior notes due 2034
YahooTD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140
BenzingaIs Encompass Health (EHC) Cheap After Its Earnings Beat And Higher 2026 Guidance?
YahooEncompass Health (EHC) Stock Trades Below Fair Value After a 110% Run
YahooEncompass Health Q2 Earnings Call Highlights
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$87.68B
THCTenet Healthcare Corporation
$21.34B
FMSFresenius Medical Care AG
$12.06B
DVADaVita Inc.
$11.74B
UHSUniversal Health Services, Inc.
$10.00B
ENSGThe Ensign Group, Inc.
$9.95B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B













